Bryan Fellman

机构：The University of Texas MD Anderson Cancer Center, Bryan College · ORCID：0000-0002-1810-5762

发表论文 435 篇 · 总被引 5410 次 · h-index 41

代表论文

Managing fatigue with methylphenidate and physical activity during cancer immunotherapy treatment (2025 · Palliative & Supportive Care · 被引 2)
Data from First-In-Human Trial of Encapsulated Cells Constitutively Expressing Localized IL2 in Patients with High-Grade Serous Ovarian Carcinoma (2026)
Supplementary Figure S7 from First-In-Human Trial of Encapsulated Cells Constitutively Expressing Localized IL2 in Patients with High-Grade Serous Ovarian Carcinoma (2026)
Supplementary Figure S2 from First-In-Human Trial of Encapsulated Cells Constitutively Expressing Localized IL2 in Patients with High-Grade Serous Ovarian Carcinoma (2026)
Supplementary Figure S5 from First-In-Human Trial of Encapsulated Cells Constitutively Expressing Localized IL2 in Patients with High-Grade Serous Ovarian Carcinoma (2026)
Supplementary Figure S8 from First-In-Human Trial of Encapsulated Cells Constitutively Expressing Localized IL2 in Patients with High-Grade Serous Ovarian Carcinoma (2026)